TreeWAS – Variant ID: rs1775453

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Y57 Other and unspecified drugs and medicaments	0.059	0.941	0.000
Y57.9 Drug or medicament, unspecified	0.056	0.944	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.056	0.944	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.054	0.946	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.054	0.946	0.000
Y57.8 Other drugs and medicaments	0.054	0.946	0.000
Y42.5 Other oestrogens and progestogens	0.051	0.949	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.051	0.949	0.000
Y57.5 X-ray contrast media	0.049	0.951	0.000
Y48 Anaesthetics and therapeutic gases	0.048	0.952	0.000
Y45.0 Opioids and related analgesics	0.048	0.952	0.000
Y45.2 Propionic acid derivatives	0.047	0.953	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.047	0.953	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.046	0.954	0.000
Y42.2 Antithyroid drugs	0.045	0.955	0.000
Y49.2 Other and unspecified antidepressants	0.045	0.955	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.044	0.956	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.043	0.957	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.042	0.958	0.000
Y57.7 Vitamins, not elsewhere classified	0.042	0.958	0.000
Y57.4 Pharmaceutical excipients	0.042	0.958	0.000
Y57.3 Alcohol deterrents	0.042	0.958	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.042	0.958	0.000
Y57.1 Lipotropic drugs	0.042	0.958	0.000
Y57.0 Appetite depressants [anorectics]	0.042	0.958	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.042	0.958	0.000
Y45.4 Antirheumatics	0.042	0.958	0.000
Y42.7 Androgens and anabolic congeners	0.042	0.958	0.000
Y45.8 Other analgesics and antipyretics	0.042	0.958	0.000
Y42.1 Thyroid hormones and substitutes	0.041	0.958	0.000
Y59 Other and unspecified vaccines and biological substances	0.041	0.958	0.000
Y57.6 Other diagnostic agents	0.041	0.959	0.000
Y48.3 Local anaesthetics	0.041	0.959	0.000
Y45.5 4-Aminophenol derivatives	0.041	0.959	0.000
Y45.1 Salicylates	0.041	0.959	0.000
Y54.3 Benzothiadiazine derivatives	0.040	0.960	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.040	0.960	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.039	0.961	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.039	0.961	0.000
Y58 Bacterial vaccines	0.039	0.961	0.000
Y42.4 Oral contraceptives	0.039	0.961	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.039	0.961	0.000
Y48.4 Anaesthetic, unspecified	0.038	0.962	0.000
Y42.9 Other and unspecified hormone antagonists	0.038	0.962	0.000
Y54.8 Agents affecting uric acid metabolism	0.037	0.963	0.000
Y54.0 Mineralocorticoids	0.037	0.963	0.000
Y49.9 Psychotropic drug, unspecified	0.036	0.963	0.000
Y49.7 Psychostimulants with abuse potential	0.036	0.963	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.036	0.963	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.036	0.963	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.036	0.963	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.036	0.963	0.000
Y43 Primarily systemic agents	0.036	0.964	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.036	0.964	0.000
Y44 Agents primarily affecting blood constituents	0.035	0.965	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.035	0.965	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.035	0.965	0.000
Y54.4 Loop [high-ceiling] diuretics	0.035	0.965	0.000
Y54.7 Agents affecting calcification	0.035	0.965	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.034	0.965	0.000
Y48.5 Therapeutic gases	0.034	0.966	0.000
Y48.1 Parenteral anaesthetics	0.034	0.966	0.000
Y48.0 Inhaled anaesthetics	0.034	0.966	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.034	0.966	0.000
Y54.9 Mineral salts, not elsewhere classified	0.034	0.966	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.034	0.966	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.034	0.966	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.034	0.966	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.034	0.966	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.033	0.967	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.033	0.967	0.000
Y53.2 Stimulant laxatives	0.032	0.968	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.032	0.968	0.000
Y59.3 Immunoglobulin	0.032	0.968	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.032	0.968	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.032	0.968	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.032	0.968	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.031	0.968	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.031	0.968	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.031	0.968	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.031	0.968	0.000
Y51.0 Anticholinesterase agents	0.031	0.968	0.000
Y56.3 Emollients, demulcents and protectants	0.031	0.969	0.000
Y56.9 Topical agent, unspecified	0.031	0.969	0.000
Y56.8 Other topical agents	0.031	0.969	0.000
Y56.7 Dental drugs, topically applied	0.031	0.969	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.031	0.969	0.000
Y56.5 Ophthalmological drugs and preparations	0.031	0.969	0.000
Y56.2 Local astringents and local detergents	0.031	0.969	0.000
Y56.1 Antipruritics	0.031	0.969	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.031	0.969	0.000
Y49.5 Other antipsychotics and neuroleptics	0.031	0.969	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.030	0.969	0.000
Y53.7 Emetics	0.030	0.969	0.000
Y53.5 Digestants	0.030	0.969	0.000
Y53.0 Histamine H2-receptor antagonists	0.030	0.969	0.000
Y53.6 Antidiarrhoeal drugs	0.030	0.969	0.000
Y48.2 Other and unspecified general anaesthetics	0.030	0.969	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.030	0.970	0.000
Y59.9 Vaccine or biological substance, unspecified	0.030	0.970	0.000
Y59.8 Other specified vaccines and biological substances	0.030	0.970	0.000
Y59.2 Protozoal vaccines	0.030	0.970	0.000
Y59.1 Rickettsial vaccines	0.030	0.970	0.000
Y53.3 Saline and osmotic laxatives	0.029	0.971	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.029	0.971	0.000
Y53.4 Other laxatives	0.029	0.971	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.028	0.971	0.000
Y59.0 Viral vaccines	0.028	0.971	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.028	0.971	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.028	0.972	0.000
Y55.5 Anticommon cold drugs	0.028	0.972	0.000
Y55.3 Antitussives	0.028	0.972	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.028	0.972	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.028	0.972	0.000
Y50.9 Central nervous system stimulant, unspecified	0.028	0.972	0.000
Y50.8 Other central nervous system stimulants	0.028	0.972	0.000
Y50.1 Opioid receptor antagonists	0.028	0.972	0.000
Y50.0 Analeptics	0.028	0.972	0.000
Y43.0 Antiallergic and antiemetic drugs	0.028	0.972	0.000
Y58.9 Other and unspecified bacterial vaccines	0.028	0.972	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.028	0.972	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.028	0.972	0.000
Y58.5 Diphtheria vaccine	0.028	0.972	0.000
Y58.4 Tetanus vaccine	0.028	0.972	0.000
Y58.3 Plague vaccine	0.028	0.972	0.000
Y58.2 Cholera vaccine	0.028	0.972	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.028	0.972	0.000
Y54.5 Other diuretics	0.028	0.972	0.000
Y43.1 Antineoplastic antimetabolites	0.028	0.972	0.000
Y55.0 Oxytocic drugs	0.028	0.972	0.000
Y52 Agents primarily affecting the cardiovascular system	0.028	0.972	0.000
Y43.2 Antineoplastic natural products	0.028	0.972	0.000
Y43.4 Immunosuppressive agents	0.028	0.972	0.000
Y46.5 Valproic acid	0.028	0.972	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.027	0.973	0.000
Y44.6 Natural blood and blood products	0.027	0.973	0.000
Y58.0 BCG vaccine	0.027	0.973	0.000
Y55.4 Expectorants	0.027	0.973	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.026	0.974	0.000
Y43.9 Primarily systemic agent, unspecified	0.026	0.974	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.026	0.974	0.000
Y43.6 Enzymes, not elsewhere classified	0.026	0.974	0.000
Y43.5 Acidifying and alkalising agents	0.026	0.974	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.026	0.974	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.026	0.974	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.026	0.974	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.026	0.974	0.000
Y47.4 Bromine compounds	0.026	0.974	0.000
Y47.3 Paraldehyde	0.026	0.974	0.000
Y47.2 Chloral derivatives	0.026	0.974	0.000
Y47.0 Barbiturates, not elsewhere classified	0.026	0.974	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.026	0.974	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.026	0.974	0.000
Y44.7 Plasma substitutes	0.026	0.974	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.026	0.974	0.000
Y46.2 Hydantoin derivatives	0.025	0.975	0.000
Y46.8 Antispasticity drugs	0.025	0.975	0.000
Y46.3 Deoxybarbiturates	0.025	0.975	0.000
Y46.1 Oxazolidinediones	0.025	0.975	0.000
Y46.0 Succinimides	0.025	0.975	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.025	0.975	0.000
E11.4 With neurological complications	0.024	0.976	0.000
Y46.7 Anti-Parkinsonism drugs	0.023	0.977	0.000
Y46.6 Other and unspecified antiepileptics	0.023	0.977	0.000
Y40 Systemic antibiotics	0.023	0.977	0.000
Y46.4 Iminostilbenes	0.022	0.978	0.000
Y52.7 Peripheral vasodilators	0.022	0.978	0.000
E11 Non-insulin-dependent diabetes mellitus	0.022	0.978	0.000
E11.5 With peripheral circulatory complications	0.022	0.978	0.000
Y47.1 Benzodiazepines	0.021	0.979	0.000
Y44.5 Thrombolytic drugs	0.021	0.979	0.000
Y41.5 Antiviral drugs	0.021	0.979	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.021	0.979	0.000
Y41.4 Anthelminthics	0.021	0.979	0.000
Y41.3 Other antiprotozoal drugs	0.021	0.979	0.000
E11.2 With renal complications	0.021	0.979	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.020	0.980	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.020	0.980	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.019	0.981	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.019	0.981	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.019	0.981	0.000
E11.3 With ophthalmic complications	0.019	0.981	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.018	0.981	0.000
E11.6 With other specified complications	0.018	0.982	0.000
Y41.0 Sulphonamides	0.018	0.982	0.000
Y44.2 Anticoagulants	0.018	0.982	0.000
U80.1 Methicillin resistant agent	0.000	0.982	0.018
Y40.1 Cefalosporins and other -lactam antibiotics	0.017	0.983	0.000
Y41.1 Antimycobacterial drugs	0.017	0.983	0.000
E11.8 With unspecified complications	0.017	0.983	0.000
E11.0 With coma	0.017	0.983	0.000
Y40.6 Rifamycins	0.017	0.983	0.000
E11.7 With multiple complications	0.017	0.983	0.000
Y40.2 Chloramphenicol group	0.016	0.983	0.000
Y40.7 Antifungal antibiotics, systemically used	0.016	0.983	0.000
Y40.8 Other systemic antibiotics	0.016	0.984	0.000
Y52.1 Calcium-channel blockers	0.016	0.984	0.000
Y40.5 Aminoglycosides	0.016	0.984	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.016	0.984	0.000
Y40.4 Tetracyclines	0.015	0.984	0.000
Y40.3 Macrolides	0.015	0.985	0.000
E11.1 With ketoacidosis	0.013	0.987	0.000
T82.8 Other complications of cardiac and vascular prosthetic devices, implants and grafts	0.013	0.987	0.000
T82 Complications of cardiac and vascular prosthetic devices, implants and grafts	0.012	0.988	0.000
Y40.9 Systemic antibiotic, unspecified	0.012	0.988	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.011	0.988	0.000
U80 Agent resistant to penicillin and related antibiotics	0.000	0.988	0.011
Y40.0 Penicillins	0.011	0.989	0.000
T82.6 Infection and inflammatory reaction due to cardiac valve prosthesis	0.011	0.989	0.000
T82.0 Mechanical complication of heart valve prosthesis	0.011	0.989	0.000
U80.0 Penicillin resistant agent	0.000	0.990	0.010
T82.9 Unspecified complication of cardiac and vascular prosthetic device, implant and graft	0.010	0.990	0.000
T82.7 Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts	0.010	0.990	0.000
C67.2 Lateral wall of bladder	0.000	0.990	0.010
T82.2 Mechanical complication of coronary artery bypass and valve grafts	0.009	0.991	0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.009	0.991	0.000
T82.4 Mechanical complication of vascular dialysis catheter	0.009	0.991	0.000
T82.1 Mechanical complication of cardiac electronic device	0.008	0.991	0.000
Y43.3 Other antineoplastic drugs	0.008	0.992	0.000
C67 Malignant neoplasm of bladder	0.000	0.992	0.008
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.008	0.992	0.000
C67.0 Trigone of bladder	0.000	0.993	0.007
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.007	0.993	0.000
M06.9 Rheumatoid arthritis, unspecified	0.007	0.993	0.000
R94.3 Abnormal results of cardiovascular function studies	0.007	0.993	0.000
C67.3 Anterior wall of bladder	0.000	0.993	0.007
C67.5 Bladder neck	0.000	0.993	0.007
C67.8 Overlapping lesion of bladder	0.000	0.993	0.007
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.007	0.993	0.000
T82.3 Mechanical complication of other vascular grafts	0.006	0.994	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.006	0.994	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.006	0.994	0.000
C67.7 Urachus	0.000	0.994	0.006
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.994	0.006
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.006	0.994	0.000
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.006	0.994	0.000
C67.4 Posterior wall of bladder	0.000	0.994	0.006
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.994	0.006
Z52.4 Kidney donor	0.000	0.994	0.006
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.006	0.994	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.005	0.995	0.000
C67.6 Ureteric orifice	0.000	0.995	0.005
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.005	0.995	0.000
N75.0 Cyst of Bartholin's gland	0.000	0.995	0.005
N81.9 Female genital prolapse, unspecified	0.000	0.995	0.005
R59.0 Localised enlarged lymph nodes	0.005	0.995	0.000
C67.1 Dome of bladder	0.000	0.995	0.004
M89.94 Disorder of bone, unspecified (Hand)	0.004	0.996	0.000
U50 Level of care administered to neonates	0.000	0.996	0.004
U07 Emergency use of U07	0.000	0.996	0.004
U06 Emergency use of U06	0.000	0.996	0.004
U04 Severe acute respiratory syndrome [SARS]	0.000	0.996	0.004
U52 First in a series of a regular day/night admissions	0.000	0.996	0.004
U51 Admission status on psychiatric patients	0.000	0.996	0.004
Z03.1 Observation for suspected malignant neoplasm	0.000	0.996	0.004
C67.9 Bladder, unspecified	0.000	0.996	0.004
Z86.1 Personal history of infectious and parasitic diseases	0.004	0.996	0.000
Z95.3 Presence of xenogenic heart valve	0.004	0.996	0.000
M89.8 Other specified disorders of bone	0.004	0.996	0.000
H21.8 Other specified disorders of iris and ciliary body	0.000	0.996	0.004
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.004	0.996	0.000
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.996	0.004
N17.9 Acute renal failure, unspecified	0.004	0.996	0.000
S50.9 Superficial injury of forearm, unspecified	0.004	0.996	0.000
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.004	0.996	0.000
N76.2 Acute vulvitis	0.000	0.996	0.004
M89 Other disorders of bone	0.004	0.996	0.000
M89.9 Disorder of bone, unspecified	0.004	0.996	0.000
N83.1 Corpus luteum cyst	0.000	0.996	0.004
M89.81 Other specified disorders of bone (Shoulder region)	0.003	0.996	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.003	0.997	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.997	0.003
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.997	0.003
U06.9 Emergency use of U06.9	0.000	0.997	0.003
U06.8 Emergency use of U06.8	0.000	0.997	0.003
U06.7 Emergency use of U06.7	0.000	0.997	0.003
U06.6 Emergency use of U06.6	0.000	0.997	0.003
U06.5 Emergency use of U06.5	0.000	0.997	0.003
U06.4 Emergency use of U06.4	0.000	0.997	0.003
U06.3 Emergency use of U06.3	0.000	0.997	0.003
U06.2 Emergency use of U06.2	0.000	0.997	0.003
U06.1 Emergency use of U06.1	0.000	0.997	0.003
U06.0 Emergency use of U06.0	0.000	0.997	0.003
U07.9 Emergency use of U07.9	0.000	0.997	0.003
U07.8 Emergency use of U07.8	0.000	0.997	0.003
U07.7 Emergency use of U07.7	0.000	0.997	0.003
U07.6 Emergency use of U07.6	0.000	0.997	0.003
U07.5 Emergency use of U07.5	0.000	0.997	0.003
U07.4 Emergency use of U07.4	0.000	0.997	0.003
U07.3 Emergency use of U07.3	0.000	0.997	0.003
U07.2 Emergency use of U07.2	0.000	0.997	0.003
U07.1 Emergency use of U07.1	0.000	0.997	0.003
U07.0 Emergency use of U07.0	0.000	0.997	0.003
U50.9 Inquest Adjourned Death	0.000	0.997	0.003
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.997	0.003
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.997	0.003
U50.1 Level of care administered to neonates (Special Care)	0.000	0.997	0.003
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.997	0.003
M89.88 Other specified disorders of bone (Other)	0.003	0.997	0.000
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.997	0.003
M89.83 Other specified disorders of bone (Forearm)	0.003	0.997	0.000
H50.1 Divergent concomitant strabismus	0.003	0.997	0.000
M89.84 Other specified disorders of bone (Hand)	0.003	0.997	0.000
Z85.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues	0.003	0.997	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.997	0.003
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.003	0.997	0.000
M89.0 Algoneurodystrophy	0.003	0.997	0.000
G63.2 Diabetic polyneuropathy	0.003	0.997	0.000
M89.3 Hypertrophy of bone	0.003	0.997	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.003	0.997	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.003	0.997	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.997	0.003
M89.91 Disorder of bone, unspecified (Shoulder region)	0.003	0.997	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.003	0.997	0.000
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.003	0.997	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.003	0.997	0.000
M89.95 Disorder of bone, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.003	0.997	0.000
M89.4 Other hypertrophic osteo-arthropathy	0.003	0.997	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.003	0.997	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.003	0.997	0.000
M89.5 Osteolysis	0.003	0.997	0.000
M89.98 Disorder of bone, unspecified (Other)	0.003	0.997	0.000
M89.6 Osteopathy after poliomyelitis	0.003	0.997	0.000
M89.2 Other disorders of bone development and growth	0.003	0.997	0.000
M89.1 Epiphyseal arrest	0.003	0.997	0.000
Z50.5 Speech therapy	0.003	0.997	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.003	0.997	0.000
N75 Diseases of Bartholin's gland	0.000	0.997	0.003
S42.40 Fracture of lower end of humerus (closed)	0.000	0.997	0.003
M65.93 Synovitis and tenosynovitis, unspecified (Forearm)	0.003	0.997	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.003	0.997	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.003	0.997	0.000
H21.0 Hyphaema	0.000	0.997	0.003
L40.5 Arthropathic psoriasis	0.003	0.997	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.003	0.997	0.000
M89.37 Hypertrophy of bone (Ankle and foot)	0.003	0.997	0.000
G62.9 Polyneuropathy, unspecified	0.003	0.997	0.000
M65.97 Synovitis and tenosynovitis, unspecified (Ankle and foot)	0.003	0.997	0.000
C78.0 Secondary malignant neoplasm of lung	0.003	0.997	0.000
Z00.5 Examination of potential donor of organ and tissue	0.000	0.997	0.003
Z90.8 Acquired absence of other organs	0.003	0.997	0.000
M23.20 Derangement of meniscus due to old tear or injury (Multiple sites)	0.000	0.997	0.003
Z45.1 Adjustment and management of infusion pump	0.003	0.997	0.000
H21 Other disorders of iris and ciliary body	0.000	0.997	0.003
M06 Other rheumatoid arthritis	0.003	0.997	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.997	0.000
N70.9 Salpingitis and oophoritis, unspecified	0.000	0.997	0.003
M89.08 Algoneurodystrophy (Other)	0.002	0.997	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.997	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.997	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.002	0.997	0.000
M89.38 Hypertrophy of bone (Other)	0.002	0.997	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.002	0.997	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.002	0.997	0.000
M89.34 Hypertrophy of bone (Hand)	0.002	0.997	0.000
M89.33 Hypertrophy of bone (Forearm)	0.002	0.997	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.002	0.997	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.002	0.997	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.002	0.997	0.000
N75.8 Other diseases of Bartholin's gland	0.000	0.997	0.002
T90.2 Sequelae of fracture of skull and facial bones	0.002	0.997	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
N75.9 Disease of Bartholin's gland, unspecified	0.000	0.998	0.002
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
M89.56 Osteolysis (Lower leg)	0.002	0.998	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.002	0.998	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.002	0.998	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.002	0.998	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.002	0.998	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.002	0.998	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.002	0.998	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.002	0.998	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.002	0.998	0.000
U81.0 Vancomycin resistant agent	0.000	0.998	0.002
G63 Polyneuropathy in diseases classified elsewhere	0.002	0.998	0.000
N17 Acute renal failure	0.002	0.998	0.000
Chapter XXII Codes for special purposes	0.000	0.998	0.002
M89.59 Osteolysis (Site unspecified)	0.002	0.998	0.000
M89.58 Osteolysis (Other)	0.002	0.998	0.000
M89.57 Osteolysis (Ankle and foot)	0.002	0.998	0.000
M89.54 Osteolysis (Hand)	0.002	0.998	0.000
M89.53 Osteolysis (Forearm)	0.002	0.998	0.000
M89.52 Osteolysis (Upper arm)	0.002	0.998	0.000
M89.51 Osteolysis (Shoulder region)	0.002	0.998	0.000
M89.50 Osteolysis (Multiple sites)	0.002	0.998	0.000
M89.19 Epiphyseal arrest (Site unspecified)	0.002	0.998	0.000
M89.18 Epiphyseal arrest (Other)	0.002	0.998	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.002	0.998	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.002	0.998	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.002	0.998	0.000
M89.14 Epiphyseal arrest (Hand)	0.002	0.998	0.000
M89.13 Epiphyseal arrest (Forearm)	0.002	0.998	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.002	0.998	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.002	0.998	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.002	0.998	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.002	0.998	0.000
M89.28 Other disorders of bone development and growth (Other)	0.002	0.998	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.002	0.998	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.002	0.998	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.002	0.998	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.002	0.998	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.002	0.998	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.002	0.998	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.002	0.998	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.002	0.998	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.002	0.998	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.002	0.998	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.002	0.998	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.002	0.998	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.002	0.998	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.002	0.998	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.002	0.998	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.002	0.998	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.002	0.998	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.002	0.998	0.000
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
H44.2 Degenerative myopia	0.002	0.998	0.000
M86.9 Osteomyelitis, unspecified	0.002	0.998	0.000
M86 Osteomyelitis	0.002	0.998	0.000
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.002	0.998	0.000
N17.8 Other acute renal failure	0.002	0.998	0.000
D28.2 Uterine tubes and ligaments	0.000	0.998	0.002
G62 Other polyneuropathies	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
M86.6 Other chronic osteomyelitis	0.002	0.998	0.000
N17.0 Acute renal failure with tubular necrosis	0.002	0.998	0.000
L60.0 Ingrowing nail	0.002	0.998	0.000
M06.1 Adult-onset Still's disease	0.002	0.998	0.000
H21.2 Degeneration of iris and ciliary body	0.000	0.998	0.002
S50.0 Contusion of elbow	0.002	0.998	0.000
M86.98 Osteomyelitis, unspecified (Other)	0.002	0.998	0.000
N70.1 Chronic salpingitis and oophoritis	0.000	0.998	0.002
H21.1 Other vascular disorders of iris and ciliary body	0.000	0.998	0.002
O90.9 Complication of the puerperium, unspecified	0.002	0.998	0.000
O90.2 Haematoma of obstetric wound	0.002	0.998	0.000
N70 Salpingitis and oophoritis	0.000	0.998	0.002
I21.2 Acute transmural myocardial infarction of other sites	0.002	0.998	0.000
Z52 Donors of organs and tissues	0.000	0.998	0.002
H21.9 Disorder of iris and ciliary body, unspecified	0.000	0.998	0.002
H21.3 Cyst of iris, ciliary body and anterior chamber	0.000	0.998	0.002
S42.00 Fracture of clavicle (closed)	0.002	0.998	0.000
M06.2 Rheumatoid bursitis	0.002	0.998	0.000
M86.1 Other acute osteomyelitis	0.002	0.998	0.000
I21.0 Acute transmural myocardial infarction of anterior wall	0.002	0.998	0.000
M06.8 Other specified rheumatoid arthritis	0.002	0.998	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.998	0.002
M86.68 Other chronic osteomyelitis (Other)	0.002	0.998	0.000
L40 Psoriasis	0.002	0.998	0.000
O90 Complications of the puerperium, not elsewhere classified	0.002	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.998	0.002
M86.67 Other chronic osteomyelitis (Ankle and foot)	0.002	0.998	0.000
L40.9 Psoriasis, unspecified	0.002	0.998	0.000
S13.4 Sprain and strain of cervical spine	0.000	0.998	0.002
C81 Hodgkin's disease	0.002	0.998	0.000
T31.0 Burns involving less than 10% of body surface	0.000	0.998	0.002
S50 Superficial injury of forearm	0.002	0.998	0.000
H65.3 Chronic mucoid otitis media	0.000	0.998	0.002
M86.4 Chronic osteomyelitis with draining sinus	0.002	0.998	0.000
C81.1 Nodular sclerosis	0.002	0.998	0.000
G63.8 Polyneuropathy in other diseases classified elsewhere	0.002	0.998	0.000
G63.6 Polyneuropathy in other musculoskeletal disorders	0.002	0.998	0.000
G63.5 Polyneuropathy in systemic connective tissue disorders	0.002	0.998	0.000
G63.4 Polyneuropathy in nutritional deficiency	0.002	0.998	0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases	0.002	0.998	0.000
G63.1 Polyneuropathy in neoplastic disease	0.002	0.998	0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.002	0.998	0.000
N17.2 Acute renal failure with medullary necrosis	0.002	0.998	0.000
M86.17 Other acute osteomyelitis (Ankle and foot)	0.002	0.998	0.000
H21.4 Pupillary membranes	0.000	0.998	0.002
M06.19 Adult-onset Still's disease (Site unspecified)	0.002	0.998	0.000
M86.93 Osteomyelitis, unspecified (Forearm)	0.002	0.998	0.000
M86.92 Osteomyelitis, unspecified (Upper arm)	0.002	0.998	0.000
M86.91 Osteomyelitis, unspecified (Shoulder region)	0.002	0.998	0.000
M86.90 Osteomyelitis, unspecified (Multiple sites)	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
C81.2 Mixed cellularity	0.002	0.998	0.000
G62.0 Drug-induced polyneuropathy	0.002	0.998	0.000
L40.3 Pustulosis palmaris et plantaris	0.002	0.998	0.000
C81.7 Other Hodgkin's disease	0.002	0.998	0.000
G60.8 Other hereditary and idiopathic neuropathies	0.002	0.998	0.000
H40.0 Glaucoma suspect	0.002	0.998	0.000
M86.5 Other chronic haematogenous osteomyelitis	0.002	0.998	0.000
M86.3 Chronic multifocal osteomyelitis	0.002	0.998	0.000
M86.2 Subacute osteomyelitis	0.002	0.998	0.000
M86.0 Acute haematogenous osteomyelitis	0.002	0.998	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.002	0.998	0.000
M86-M90 Other osteopathies	0.002	0.998	0.000
C50.1 Central portion of breast	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
C66 Malignant neoplasm of ureter	0.000	0.998	0.002
G60 Hereditary and idiopathic neuropathy	0.002	0.998	0.000
M06.10 Adult-onset Still's disease (Multiple sites)	0.002	0.998	0.000
M06.32 Rheumatoid nodule (Upper arm)	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations